CI.N PE Ratio & Valuation, Is CI.N Overvalued

Historical Valuation

Cigna Group (CI.N) is now in the Undervalued zone, suggesting that its current forward PE ratio of 9.14 is considered Undervalued compared with the five-year average of 10.86. The fair price of Cigna Group (CI.N) is between 329.95 to 383.66 according to relative valuation method. Compared to the current price of 269.66 USD , Cigna Group By Undervalued By 18.27%.

Relative Value

Fair Zone

329.95-383.66

Current Price：269.66

18.27%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Cigna Group (CI.N) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Cigna Group (CI.N) has a current Price-to-Book (P/B) ratio of 1.78. Compared to its 3-year average P/B ratio of 2.02, the current P/B ratio is approximately -11.96% higher. Relative to its 5-year average P/B ratio of 1.92, the current P/B ratio is about -7.19% higher. Cigna Group (CI.N) has a Forward Free Cash Flow (FCF) yield of approximately 9.97%. Compared to its 3-year average FCF yield of 9.92%, the current FCF yield is approximately 0.50% lower. Relative to its 5-year average FCF yield of 9.42%, the current FCF yield is about 5.83% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for CI competitors is 0.25, providing a benchmark for relative valuation. Cigna Group Corp (CI.N) exhibits a P/S ratio of --, which is NaN% above the industry average. Given its robust revenue growth of 0%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of CI.N increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of CI.N in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is CI.N currently overvalued or undervalued?

What is Cigna Group (CI.N) fair value?

CI.N's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Cigna Group (CI.N) is between 329.95 to 383.66 according to relative valuation method.

How does CI.N's valuation metrics compare to the industry average?

The average P/S ratio for CI.N's competitors is 0.25, providing a benchmark for relative valuation. Cigna Group Corp (CI.N) exhibits a P/S ratio of --, which is 0% above the industry average. Given its robust revenue growth of 0%, this premium appears unsustainable.

What is the current P/B ratio for Cigna Group (CI.N) as of Mar 10 2026?

As of Mar 10 2026, Cigna Group (CI.N) has a P/B ratio of 1.78. This indicates that the market values CI.N at 1.78 times its book value.

What is the current FCF Yield for Cigna Group (CI.N) as of Mar 10 2026?

As of Mar 10 2026, Cigna Group (CI.N) has a FCF Yield of 9.97%. This means that for every dollar of Cigna Group's market capitalization, the company generates 9.97 cents in free cash flow.

What is the current Forward P/E ratio for Cigna Group (CI.N) as of Mar 10 2026?

As of Mar 10 2026, Cigna Group (CI.N) has a Forward P/E ratio of 9.14. This means the market is willing to pay $9.14 for every dollar of Cigna Group's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Cigna Group (CI.N) as of Mar 10 2026?

As of Mar 10 2026, Cigna Group (CI.N) has a Forward P/S ratio of 0.26. This means the market is valuing CI.N at $0.26 for every dollar of expected revenue over the next 12 months.

CI.N Valuation